Hep573 study: A randomised, double-blind, placebocontrolled trial of silymarin alone and combined with antioxidants to improve liver function and quality of life in people with chronic hepatitis C

Ses J. Salmond, J. George, S. I. Strasser, K. Byth, B. Rawlinson, T. A. Mori, K. D. Croft, L. A. Adams, R. G. Batey

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Hep573 study: A randomised, double-blind, placebocontrolled trial of silymarin alone and combined with antioxidants to improve liver function and quality of life in people with chronic hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences